AzTrials
AzTrials

BruxismCHAINSPORTNCT07556211

Neuromuscular Function and Performance in Athletes With or Without Bruxism

An observational study of Bruxism, run by Mainjot Amélie at 1 site in Belgium.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to evaluate the associations between bruxism and neuromuscular function, as well as athletic performance, in a population of amateur athletes. Particular attention will be paid to musculoskeletal disorders associated with bruxism, particularly in the shoulder. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Bruxism
How many people
120 participants
Where
1 siteBelgium
Study dates
1 Aug 2026to 1 Jul 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Amateur athletes from the Province of Liège

Who may be able to join

  • Practices swimming or handball 3 to 8 hours per week.
  • Has the cognitive/mental capacity to take part in this study.
  • Fluent in the language of the survey (French).

Who cannot join

  • Current orthodontic treatment or treatment completed within the last 2 months.
  • Shoulder and/or cervical spine injury or surgery within the past 6 months.
  • Current cessation or limitation of sports activity due to shoulder and/or cervical symptoms at the time of participation.
  • Any pathology or history of trauma to the dominant hand resulting in reduced grip strength.
  • Any clinically manifest infectious episode at the time of participation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Belgium1 site
  • University of Liège

    Liège, 4020

Other trials in Belgium

About this study

Official title: Is Bruxism Associated With Altered Systemic Neuromuscular Function and Increased Risk of Muscular Injury ?

The aim of this study is to evaluate the associations between bruxism and neuromuscular function, as well as athletic performance, in a population of amateur athletes. Particular attention will be paid to musculoskeletal disorders associated with bruxism, particularly in the shoulder. Participants' history of sports injuries will also be recorded. To control for the effect of potential confounding variables, levels of stress, anxiety, and mood, as well as sleep quality, will be systematically measured using validated questionnaires.

Conditions
Bruxism
Medical subject headings
Bruxism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07556211
Study groupRoleWhat they receive
athleteamateur athletes in the Province of Liège, aged between 18 and 35

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscular Tone

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    F - Natural Oscillation Frequency [Hz], characterizing Tone or Tension (higher values = higher tension)

    Measured: Baseline

  2. Dynamic Stiffness

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    S - Dynamic Stiffness [N/m] (This biophysical parameter reflects the muscle's ability to resist contractions or external stresses to deformation, it can increased with exercice or pain)

    Measured: Baseline

  3. Muscular elasticity

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives parameter of the neuromuscular function:

    D - Logarithmic Decrement [relative unit], characterizing Elasticity (Higher values = lower elasticity)

    Measured: Baseline

  4. Muscular Mechanical Stress Relaxation Time

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    R - Mechanical Stress Relaxation Time [ms] (low value correspond to fast tissue recovers its shape)

    Measured: Baseline

  5. Muscular Creep

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    C - Ratio of Relaxation and Deformation time [relative unit], characterizing Creep (Higher Creep Value: Indicates higher fluidity, meaning the muscle is less rigid)

    Measured: Baseline

  6. Maximal grip strength test

    Will be evaluated with the Eforto device, which is the first validated device to measure maximal grip strength test. One value in kPa. Higher values indicate higher muscle strength.

    Measured: Baseline

  7. Muscle fatigue

    Will be evaluated with the Eforto device, which is the first validated device to measure muscle fatigability (fatigue resistance test, which was shown to reflect the level of both muscle energy and metabolism, neuromuscular function, and immune and stress responses). One value obtained, in seconds. Cut-off normative values in healthy 25-35 year-old male and female people are available, and lower values indicate increased muscle fatigability.

    Measured: Baseline

  8. Trapeze isometric force

    Will be evaluated with dynamometer, higher values (unit is N) meaning higher muscular isometric force

    Measured: Baseline

  9. Muscular Tone

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    F - Natural Oscillation Frequency [Hz], characterizing Tone or Tension (higher values = higher tension)

    Measured: 15-30 minutes after training

  10. Dynamic Stiffness

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    S - Dynamic Stiffness [N/m] (This biophysical parameter reflects the muscle's ability to resist contractions or external stresses to deformation, it can increased with exercice or pain)

    Measured: 15-30 minutes after training

  11. Muscular elasticity

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives parameter of the neuromuscular function:

    D - Logarithmic Decrement [relative unit], characterizing Elasticity (Higher values = lower elasticity)

    Measured: 15-30 minutes after training

  12. Muscular Mechanical Stress Relaxation Time

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    R - Mechanical Stress Relaxation Time [ms] (low value correspond to fast tissue recovers its shape)

    Measured: 15-30 minutes after training

  13. Muscular Creep

    Myotonometry will be performed with the MyotonPRO device, a digital palpation device, on the masseter, sternocleidomastoid, upper trapezius, erector spinae and quadriceps muscles at rest,

    The device gives :

    C - Ratio of Relaxation and Deformation time [relative unit], characterizing Creep (Higher Creep Value: Indicates higher fluidity, meaning the muscle is less rigid)

    Measured: 15-30 minutes after training

Secondary outcomes (4)
  1. Shoulder - passive range of motion

    Measurement of passive range of motion in internal and external rotation of the shoulder using a goniometer (in degrees), with the arm abducted 90° in the frontal plane. The higher values correspond to the higher passive range of motion

    Measured: Baseline

  2. Cervical spine mobility

    Cervical spine mobility (flexion, extension, lateral flexion to the right and left, and rotation to the right and left). Assessment using a ordinal scale with values : Good, limited, very limited, from better to worse outcomes.

    Measured: Baseline

  3. Athletic performance

    Athletic performance will be assessed and measured at the start of training and after the warm-up using a test specific to each sport.

    For swimmers, a 50-meter crawl at maximum speed will be timed. For handball players, a T-test will be conducted and measured using photoelectric sensors. This test evaluates speed and accuracy on a course of cones arranged in a T-shape with specific distances between the cones (spaced 5 to 10 meters apart).

    The lower values correspond to the better athletic performance.

    Measured: Baseline

  4. History of sports injuries

    Obtained through questioning following International Olympic Committee guidelines. Descriptive outcome. Score severity according to the number and the severity of the injuries.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2026
  2. Study start1 Aug 2026 (estimated)
  3. Primary completion1 Jul 2028 (estimated)
  4. Study completion1 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07556211
Sponsor's protocol ID
2026/241
Acronym
CHAINSPORT
Status last verified
Apr 2026
First submitted
9 Apr 2026
Last updated
29 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bruxism, run by Mainjot Amélie at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscular Tone (time frame: Baseline). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in